Conjunctivitis, Bacterial - 18 Studies Found

Completed : Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis
: Conjunctivitis, Bacterial
: 2006-07-25
: Drug: Azithromycin (T1225)
Completed : Systemic Pharmacokinetics of BOL-303224-A
: Conjunctivitis, Bacterial
: 2006-12-01
: Drug: BOL-303224-A 1 drop in each eye, TID for 5 days at approximately 6 h intervals, with a final, sing
Completed : AL-15469A for the Treatment of Bacterial Conjunctivitis
: Bacterial Conjunctivitis
: 2006-05-31
:
  • Drug: Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5%

Completed : Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora
: Bacterial Conjunctivitis
: 2006-04-04
: Drug: VIGAMOX 1 drop of VIGAMOX® ophthalmic solution 0.5% in both eyes TID for 7 days
Completed : Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis
: Bacterial Conjunctivitis
: 2008-02-14
:
  • Drug: ISV-403 0.6% TID, 5 days
Recruiting : Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
: Bacterial Conjunctivitis
: 2016-12-19
:
  • Drug: SHP640 Instill 1 drop of
Completed : Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
: Bacterial Conjunctivitis
: 2009-09-04
:
  • Drug: Besifloxacin Besifloxaci
Terminated : Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis
: Bacterial Conjunctivitis
: 2012-11-29
:
  • Drug: Besifloxacin one drop of
Recruiting : Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
: Bacterial Conjunctivitis
: 2015-04-29
:
  • Drug: Vancomycin 1.1% Vancomyc
Terminated : Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial Conjunctivitis
: Bacterial Conjunctivitis
: 2011-04-05
:
  • Drug: Besivance Besifloxacin h
Next >>>